Improving Genome Editing with Enhanced CRISPR-Cas Nucleases

Some of the greatest hurdles to the successful application of CRISPR-Cas technology in the clinic include suboptimal specificity, activity, and targeting range. In this webinar, Dr. Benjamin Kleinstiver presents a brief overview of genome editing and CRISPR technology. He then describes his lab's efforts to engineer enhanced CRISPR-Cas nucleases for improved genome editing specificity and discusses how these technologies can translate to more efficient tools and disease treatments.
Publish Date: May 21, 2019

Contact STEMCELL Technologies

Our Customer Service, Sales, and Product and Scientific Support departments in North America are available between 6 am and 5 pm Pacific Time (9 am and 8 pm Eastern Time). One of our representatives will be happy to help you by telephone or email. Please complete the form to contact us by email. A representative will get back to you shortly.

StemCell Technologies Inc. and affiliates ("STEMCELL Technologies") does not share your email address with third parties. StemCell Technologies Inc. will use your email address to confirm your identity and send you newsletters, transaction-related emails, promotional and customer service emails in accordance with our privacy policy. You can change your email preferences at any time.